MetaVia MTVA
NASDAQ MTVA
$1.35 +0.06 (+4.65%)
As of: Oct 21, 2026 · 3:38 PM EDT

MetaVia (MTVA) Convertible Debt (2018)

Updated

MetaVia (MTVA) reported Convertible Debt of $118,000 for Q4 2018.

Analysis

MetaVia (MTVA) Convertible Debt (2018) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,138.33 Bn 1,106.91 Bn 19.71 Bn
2 Johnson & Johnson 618.82 Bn 537.35 Bn 17.26 Bn
3 AbbVie 503.36 Bn 476.47 Bn 12.70 Bn
4 Merck 369.59 Bn 323.96 Bn 12.21 Bn
5 Novartis Ag 298.57 Bn 262.56 Bn 11.24 Bn
6 Astrazeneca 261.25 Bn 234.94 Bn 12.86 Bn
7 Amgen 237.35 Bn 192.75 Bn 7.24 Bn
8 Gilead Sciences 191.27 Bn 165.47 Bn 6.22 Bn
9 Pfizer 170.03 Bn 116.68 Bn 10.94 Bn
10 MetaVia 8.01 Mn -46.80 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 118,000.00
API Access

MetaVia Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=MTVA&period=max&api_key=YOUR_API_KEY